Focusing on fundamental fibrotic mechanisms common across different organs, rather than organ-specific approaches.
Developing platform therapies designed to halt fibrosis progression in multiple organ systems simultaneously.
Pursuing disease-modifying therapies that address root causes rather than merely managing symptoms.